Drugs / Recombinant zoster vaccine(CHO cell)(low adjuvant)
Recombinant zoster vaccine(CHO cell)(low adjuvant)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06851832 | Feb 2025 → Sep 2026 overdue | herpes zoster | Ab&B Bio-tech Co., Ltd.JS | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant zoster vaccine(CHO cell)(low adjuvant) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06851832 ↗ |
| Modality | Vaccine | “recombinant herpes zoster vaccine (CHO cells)” NCT06851832 ↗ |
| Route | Intramuscular | “administered intramuscularly into the deltoid muscle” NCT06851832 ↗ |